Aminostyrylbenzofuran derivatives as potent inhibitors for Aβ fibril formation

Ji Hun Byun; Hye Yun Kim; Young Soo Kim; Inhee Mook-Jung; Dong Jin Kim; Won Koo Lee; Kyung Ho Yoo

doi:10.1016/j.bmcl.2008.08.111

Aminostyrylbenzofuran derivatives as potent inhibitors for Aβ fibril formation

Ji Hun Byun, Hye Yun Kim, Young Soo Kim, Inhee Mook-Jung, Dong Jin Kim, Won Koo Lee, Kyung Ho Yoo

Department of Pharmacy

Research output: Contribution to journal › Article › peer-review

62 Citations (Scopus)

Abstract

The synthesis of a novel series of aminostyrylbenzofuran derivatives 1a-w and their inhibitory activities for Aβ fibril formation were described. All the synthesized compounds were evaluated by thioflavin T (ThT) assay and displayed potent inhibitory activities for Aβ fibril formation. Among them, compounds 1i and 1q exhibited excellent inhibitory activities (IC₅₀ = 0.07 and 0.08 μM, respectively) than those of Curcumin (IC₅₀ = 0.80 μM) and IMSB (IC₅₀ = 8.00 μM) as reference compounds. Both compounds were selected as promising candidates for further biological evaluation.

Original language	English
Pages (from-to)	5591-5593
Number of pages	3
Journal	Bioorganic and Medicinal Chemistry Letters
Volume	18
Issue number	20
DOIs	https://doi.org/10.1016/j.bmcl.2008.08.111
Publication status	Published - 2008 Oct 15

Bibliographical note

Funding Information:
We are grateful to the Ministry of Science and Technology (MOST) and Ministry of Commerce, Industry and Energy (MCIE) of Korea for financial support.

All Science Journal Classification (ASJC) codes

Biochemistry
Molecular Medicine
Molecular Biology
Pharmaceutical Science
Drug Discovery
Clinical Biochemistry
Organic Chemistry

Access to Document

10.1016/j.bmcl.2008.08.111

Cite this

@article{f2ed7218ca874bf59c6a6145acf70332,

title = "Aminostyrylbenzofuran derivatives as potent inhibitors for Aβ fibril formation",

abstract = "The synthesis of a novel series of aminostyrylbenzofuran derivatives 1a-w and their inhibitory activities for Aβ fibril formation were described. All the synthesized compounds were evaluated by thioflavin T (ThT) assay and displayed potent inhibitory activities for Aβ fibril formation. Among them, compounds 1i and 1q exhibited excellent inhibitory activities (IC50 = 0.07 and 0.08 μM, respectively) than those of Curcumin (IC50 = 0.80 μM) and IMSB (IC50 = 8.00 μM) as reference compounds. Both compounds were selected as promising candidates for further biological evaluation.",

author = "Byun, {Ji Hun} and Kim, {Hye Yun} and Kim, {Young Soo} and Inhee Mook-Jung and Kim, {Dong Jin} and Lee, {Won Koo} and Yoo, {Kyung Ho}",

note = "Funding Information: We are grateful to the Ministry of Science and Technology (MOST) and Ministry of Commerce, Industry and Energy (MCIE) of Korea for financial support.",

year = "2008",

month = oct,

day = "15",

doi = "10.1016/j.bmcl.2008.08.111",

language = "English",

volume = "18",

pages = "5591--5593",

journal = "Bioorganic and Medicinal Chemistry Letters",

issn = "0960-894X",

publisher = "Elsevier Limited",

number = "20",

}

TY - JOUR

T1 - Aminostyrylbenzofuran derivatives as potent inhibitors for Aβ fibril formation

AU - Byun, Ji Hun

AU - Kim, Hye Yun

AU - Kim, Young Soo

AU - Mook-Jung, Inhee

AU - Kim, Dong Jin

AU - Lee, Won Koo

AU - Yoo, Kyung Ho

N1 - Funding Information: We are grateful to the Ministry of Science and Technology (MOST) and Ministry of Commerce, Industry and Energy (MCIE) of Korea for financial support.

PY - 2008/10/15

Y1 - 2008/10/15

N2 - The synthesis of a novel series of aminostyrylbenzofuran derivatives 1a-w and their inhibitory activities for Aβ fibril formation were described. All the synthesized compounds were evaluated by thioflavin T (ThT) assay and displayed potent inhibitory activities for Aβ fibril formation. Among them, compounds 1i and 1q exhibited excellent inhibitory activities (IC50 = 0.07 and 0.08 μM, respectively) than those of Curcumin (IC50 = 0.80 μM) and IMSB (IC50 = 8.00 μM) as reference compounds. Both compounds were selected as promising candidates for further biological evaluation.

AB - The synthesis of a novel series of aminostyrylbenzofuran derivatives 1a-w and their inhibitory activities for Aβ fibril formation were described. All the synthesized compounds were evaluated by thioflavin T (ThT) assay and displayed potent inhibitory activities for Aβ fibril formation. Among them, compounds 1i and 1q exhibited excellent inhibitory activities (IC50 = 0.07 and 0.08 μM, respectively) than those of Curcumin (IC50 = 0.80 μM) and IMSB (IC50 = 8.00 μM) as reference compounds. Both compounds were selected as promising candidates for further biological evaluation.

UR - http://www.scopus.com/inward/record.url?scp=53349147027&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=53349147027&partnerID=8YFLogxK

U2 - 10.1016/j.bmcl.2008.08.111

DO - 10.1016/j.bmcl.2008.08.111

M3 - Article

C2 - 18793854

AN - SCOPUS:53349147027

VL - 18

SP - 5591

EP - 5593

JO - Bioorganic and Medicinal Chemistry Letters

JF - Bioorganic and Medicinal Chemistry Letters

SN - 0960-894X

IS - 20

ER -

Aminostyrylbenzofuran derivatives as potent inhibitors for Aβ fibril formation

Abstract

Bibliographical note

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this